维普期刊资源整合服务平台（V6.5）

248篇 您的检索式：作者名="HERBST D"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Self‐Healing Polymers via Supramolecular Forces显示文摘	Florian Herbst Diana D?hler Philipp Michael Wolfgang H. Binder	2013	Macromol Rapid Commun2013，，3：	2
2	NS5A inhibitor, daclatasvir , for the treatment of chronic hepatitis C virus infection显示文摘	D Alan Herbst K Rajender Reddy	2013	Expert Opinion on Investigational Drugs2013，，10：	2
3	显示文摘	HERBST D SMITH D ADAMS N G	1989	J Chem Soc Fraday Trans1989，285，10：	1
4	Improvements in Quality of Life and Disease-related Symptoms in Phase I Trials of the Selective Oral Epidermal Growth Factor Receptor Tyrosin Kinase Inhibitor ZD1839 in Non-Small Cell Lung Cancer and Other Solid Tumors显示文摘	LoRusso PM Herbst RS Rischin D	2003	Clin Cancer Res2003，9，6：	1
5	Long-term extracorporeal circulation management:the role of low-and high-range heparin ACT tests显示文摘	Herbst D Najm HK Jha KN	2008	J Extra Corpor Technol2008，40，4：	1
6	Cellular localization of type Ⅱ,Ⅲand Ⅳ procollagen gene transcripts in normal and flbrotic human liver显示文摘	Herbst H Schuppan D	1990	Am J Pathol1990，137，1：	1
7	Workflow mining with InWoLvE显示文摘	HERBST J KARAGIANNIS D	2004	Computers in Industry2004，53，3：	1
8	A time varying,convergence adjusted hedge ratio model显示文摘	Kare D D Marshall J F	1993	Advances in Futures and Options Research1993，6，：	1
9	Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinasc inhibitor ZD1839 in non-small cell lung cancer and other solid tumors显示文摘	LORUSSO PM HERBST RS RISCHIN D	2003	Clin Cancer Res2003，9，6：	1
10	Improvements in quality of life and disease-related symptoms in phase Ⅰ trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors显示文摘	Lo Russo PM Herbst RS Rischin D	2003	Clin Cancer Res2003，9，：	1
11	TRIBUTE : a phase Ⅲ trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer显示文摘	Herbst RS Prager D Hermann R	2005	J Clin Oncol2005，23，25：	1
12	A phase I/II A trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer 显示文摘	Herbst R S Hammond L A Carbone D P etal	2003	Clin Cancer Res2003，9，11：	1
13	Workflow Mining with InWoLvE显示文摘	HERBST J KARAGIANNIS D	2004	Computers in Industry2004，53，：	1
14	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non small cell lung cancer treated with chemo- therapy alone and in combination with erlotinib 显示文摘	Eberhard D A Johnson B E Amler L C Goddard A D Heldens S L Herbst R S	2005	J Clin On- col2005，23，：	1
15	Seasonal variability of interception evaporation from the canopy of a mixed deciduous forest 显示文摘	Herbst M Rosier P T W Mcneil D D	2008	Agricultural and Forest Meteorology2008，148，11：	1
16	TRIBUTE:A phase Ⅲ trial of erlotinib hydrochloride(OSI-774)combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer显示文摘	Herbst RS Prager D Hermann R	2005	J Clin Oncol2005，23，：	1
17	Development of biologic markers of response and assessment of antian-giogenic activity in a clinical trial of human recombinant endostatin 显示文摘	Herbst R S Mullani N A Davis D W	2002	J Clin Oncol2002，20，18：	1
18	显示文摘	Herbst J F Fuerst C D Misbra R K	1991	J Appl Phys1991，69，：	1
19	Differential expression of matrix metalloproeinase - 1 and - 2 genes in normal and fibrotic human liver显示文摘	Miliani S Herbst H Schuppan D	1994	Am J Pathol1994，144，：	1
20	Novel permanent magnets by high-throughput experiments显示文摘	GOLL D LOEFFLER R HERBST J	2015	The Minerals Metals &materials Society2015，67，6：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示